Emergent BioSolutions

Emergent BioSolutions Inc. is a global biotechnology company that provides biopharmaceutical products to healthcare providers and governments. The company has two operating segments: Biodefense and Biosciences. Its specialized Biodefense segment focuses on countermeasures against public health threats. The U.S. government is the primary purchaser of these products and often provides substantial funding for their development. Emergent's Biosciences business primarily concentrates on hematology and oncology treatments, followed by transplantation, infectious diseases, and autoimmune disorders.